[HTML][HTML] The co-occurrence of the SAVA syndemic, depression and anxiety as barriers to antiretroviral therapy adherence among sub-Saharan Africa population …

A Delport, H Tabana, L Knight, E Wouters - Plos one, 2022 - journals.plos.org
Introduction The scale-up of access to antiretroviral therapy has transformed HIV from an
acute, terminal disease to a manageable chronic illness. Yet, sustaining high levels of …

[HTML][HTML] The co-occurrence of the SAVA syndemic, depression and anxiety as barriers to antiretroviral therapy adherence among sub-Saharan Africa population …

A Delport, H Tabana, L Knight, E Wouters - PLoS ONE, 2022 - ncbi.nlm.nih.gov
The scale-up of access to antiretroviral therapy has transformed HIV from an acute, terminal
disease to a manageable chronic illness. Yet, sustaining high levels of antiretroviral therapy …

The co-occurrence of the SAVA syndemic, depression and anxiety as barriers to antiretroviral therapy adherence among sub-Saharan Africa population groups: A …

A Delport, H Tabana, L Knight, E Wouters - PLoS ONE, 2022 - ui.adsabs.harvard.edu
Introduction The scale-up of access to antiretroviral therapy has transformed HIV from an
acute, terminal disease to a manageable chronic illness. Yet, sustaining high levels of …

The co-occurrence of the SAVA syndemic, depression and anxiety as barriers to antiretroviral therapy adherence among sub-Saharan Africa population groups: A …

A Delport, H Tabana, L Knight, E Wouters - Plos one, 2022 - europepmc.org
The scale-up of access to antiretroviral therapy has transformed HIV from an acute, terminal
disease to a manageable chronic illness. Yet, sustaining high levels of antiretroviral therapy …

The co-occurrence of the SAVA syndemic, depression and anxiety as barriers to antiretroviral therapy adherence among sub-Saharan Africa population groups: a …

A Delport, H Tabana, L Knight, E Wouters - 2022 - cabidigitallibrary.org
Introduction: The scale-up of access to antiretroviral therapy has transformed HIV from an
acute, terminal disease to a manageable chronic illness. Yet, sustaining high levels of …

The co-occurrence of the SAVA syndemic, depression and anxiety as barriers to antiretroviral therapy adherence among sub-Saharan Africa population groups: a …

A Delport, H Tabana, L Knight, E Wouters - PLoS ONE, 2022 - repository.uantwerpen.be
Introduction The scale-up of access to antiretroviral therapy has transformed HIV from an
acute, terminal disease to a manageable chronic illness. Yet, sustaining high levels of …

[PDF][PDF] The co-occurrence of the SAVA syndemic, depression and anxiety as barriers to antiretroviral therapy adherence among sub-Saharan Africa population groups …

A Delport, H Tabana, L Knight, E Wouters - PLoS ONE, 2022 - academia.edu
The scale-up of access to antiretroviral therapy has transformed HIV from an acute, terminal
disease to a manageable chronic illness. Yet, sustaining high levels of antiretroviral therapy …

The co-occurrence of the SAVA syndemic, depression and anxiety as barriers to antiretroviral therapy adherence among sub-Saharan Africa population groups: A …

A Delport, H Tabana, L Knight, E Wouters - PloS one, 2022 - pubmed.ncbi.nlm.nih.gov
Introduction The scale-up of access to antiretroviral therapy has transformed HIV from an
acute, terminal disease to a manageable chronic illness. Yet, sustaining high levels of …

The co-occurrence of the SAVA syndemic, depression and anxiety as barriers to antiretroviral therapy adherence among sub-Saharan Africa population groups: A …

A Delport, H Tabana, L Knight, E Wouters - PLoS ONE, 2022 - psycnet.apa.org
Introduction: The scale-up of access to antiretroviral therapy has transformed HIV from an
acute, terminal disease to a manageable chronic illness. Yet, sustaining high levels of …

The co-occurrence of the SAVA syndemic, depression and anxiety as barriers to antiretroviral therapy adherence among sub-Saharan Africa population groups: A …

A Delport, H Tabana, L Knight, E Wouters - Plos one, 2022 - europepmc.org
The scale-up of access to antiretroviral therapy has transformed HIV from an acute, terminal
disease to a manageable chronic illness. Yet, sustaining high levels of antiretroviral therapy …